Literature DB >> 30790429

Hemodynamic characterization of aortic stenosis states.

Amr E Abbas1,2, Philippe Pibarot3.   

Abstract

Aortic stenosis (AS) has become an increasingly prevalent clinical condition, as a result of the "greying of the population", the widespread application of sophisticated diagnostic tools including non-invasive imaging and invasive techniques, and the advent of minimally invasive surgical and percutaneous valve therapies. The diagnosis of severe AS traditionally has relied on the assessment of the mean transvalvular gradient (ΔPmean ) and aortic valve area (AVA) by either echocardiography or catheterization. However, other hemodynamic variables as flow, pressure recovery, and jet eccentricity also play a major role in determining the final hemodynamic state of AS. Moreover, mismatch between ΔPmean and AVA as in low flow low gradient AS and discordance between catheterization and echocardiographic studies in grading severity of AS have increased the complexity of AS diagnosis. The present case-based treatise emphasizes a multi-modality approach to delineation of the hemodynamic pathophysiology of different AS states. KEY POINTS: Reduction in the aortic valve area, flow across the aortic valve, and direction of the aortic stenosis jet determine the pressure gradient generated across the aortic valve in patients with aortic stenosis. Discordance between echo and catheterization maximum gradients is related to the inherent temporal differences between the times of their acquisition. Discordance between echo and catheterization mean gradients is related to pressure recovery and assumptions in the application of Bernoulli equation to estimate the aortic valve gradient. Pressure recovery relates to the ratio of the aortic valve area and ascending aortic diameter as well as the jet direction. Mismatch between area and gradient criteria for aortic stenosis severity may occur with or without concordance between echocardiographic and catheterization data. Errors of measurement should be excluded prior to assuming any mismatch or discordance between the data. Area gradient mismatch occurs when the aortic valve area is in the severe range, while the gradient is in the non-severe range as in low flow low gradient aortic stenosis. Reverse area gradient mismatch occurs when the gradient is in the severe range, while the aortic valve area is in the non-severe range as in congenital aortic stenosis with an eccentric jet.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ECHO/CATH discordance; area/gradient mismatch; eccentric jet; low flow/low gradient AS; reverse area/gradient mismatch

Mesh:

Year:  2019        PMID: 30790429     DOI: 10.1002/ccd.28146

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Personalized intervention cardiology with transcatheter aortic valve replacement made possible with a non-invasive monitoring and diagnostic framework.

Authors:  Seyedvahid Khodaei; Alison Henstock; Reza Sadeghi; Stephanie Sellers; Philipp Blanke; Jonathon Leipsic; Ali Emadi; Zahra Keshavarz-Motamed
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

Review 2.  Multimodality Imaging for Discordant Low-Gradient Aortic Stenosis: Assessing the Valve and the Myocardium.

Authors:  Ezequiel Guzzetti; Mohamed-Salah Annabi; Philippe Pibarot; Marie-Annick Clavel
Journal:  Front Cardiovasc Med       Date:  2020-12-03

3.  Gradient and pressure recovery of a self-expandable transcatheter aortic valve depends on ascending aorta size: In vitro study.

Authors:  Milad Samaee; Hoda Hatoum; Michael Biersmith; Breandan Yeats; Shelley C Gooden; Vinod H Thourani; Rebecca T Hahn; Scott Lilly; Ajit Yoganathan; Lakshmi Prasad Dasi
Journal:  JTCVS Open       Date:  2022-01-22

4.  Outcome of transcatheter aortic valve replacement in patients over 85 years of age versus patients aged 85 and younger.

Authors:  F S van den Brink; I Wijtsma; H Amrane; T N E Vossenberg; J Haenen; F Porta; A J Van Boven; S H Hofma
Journal:  Neth Heart J       Date:  2022-05-24       Impact factor: 2.854

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.